Sean A. McCarthy - Jun 14, 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
President and CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Stock symbol
CTMX
Transactions as of
Jun 14, 2021
Transactions value $
$43
Form type
4
Date filed
6/16/2021, 09:49 PM
Previous filing
Jun 8, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Options Exercise $34.00 +30 +0.38% $1.13 7.84K Jun 14, 2021 Direct
transaction CTMX Common Stock Options Exercise $9.45 +10 +0.13% $0.95 7.85K Jun 14, 2021 Direct
holding CTMX Common Stock 193K Jun 14, 2021 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -30 -0.03% $0.00 92.1K Jun 14, 2021 Common Stock 30 $1.13 Direct F2
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -10 -0.01% $0.00 66.7K Jun 14, 2021 Common Stock 10 $0.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F2 100% of the shares subject to the option are fully vested and exercisable.